The Healthcare sector is large (10% of European GDP) and growing strongly, thanks to demographic tailwinds, a rise in chronic diseases and medical advancements, which are facilitating new diagnostic options. We advise public and private companies in the sector, and focus primarily on the following sub-sectors where we have identified the best opportunities for either growth or consolidation:

  • Clinics & Hospitals
  • Contract research organizations (CROs)
  • Healthcare IT
  • Human Pharma
  • Laboratories
  • Medical Devices
  • Veterinary Pharma

The majority of our transactions are international – both within Europe and overseas. They are executed by a team of experienced advisors across the globe. We have extensive sector expertise.

Recent insight

September 2014
Healthcare sector update

Strong deal volumes in 2014 across healthcare markets

Recent insight

team icon Team size: 13

deal icon Deals: 23

Selected transactions More transactions